menu
    • menu

    Company profile for Blade Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Blade Therapeutics is advancing innovative anti-fibrotic therapies to meet currently unserved patient needs. Several rare/orphan and chronic debilitating conditions manifest with fibrosis, a complex, pathologic process in which healthy cells are replaced by progressively worsening scar tissue (fibrosis). We are committed to developing disease modifying and lifesaving treatments.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Blade TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    442 Littlefield Avenue South San Francisco, CA 94080
    Telephone
    Telephone
    (650) 278 4291
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.blademed.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Blade Therapeutics CEO, CFO appear to depart amid 'transition' after nixed SPAC
    Blade Therapeutics CEO, CFO appear to depart amid 'transition' after nixed SPAC

    15 Dec 2022

    // Kyle LaHucik ENDPTS

    https://endpts.com/blade-therapeutics-shutting-down-executives-appear-to-leave/

    Kyle LaHucik ENDPTS
    15 Dec 2022
    Share Share
    Blade Presents Analyses from PI & Preclinical Studies of Cudetaxestat at ERSI
    Blade Presents Analyses from PI & Preclinical Studies of Cudetaxestat at ERSI

    04 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220904005002/en

    BUSINESSWIRE
    04 Sep 2022
    Share Share
    Blade Therapeutics to Participate in Panel Discussion at BTIG Biotech Conference
    Blade Therapeutics to Participate in Panel Discussion at BTIG Biotech Conference

    01 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220801005047/en

    BUSINESSWIRE
    01 Aug 2022
    Share Share
    Blade Therapeutics' SPAC merger is cancelled
    Blade Therapeutics' SPAC merger is cancelled

    14 Jun 2022

    // J. Waldron FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/another-biotech-spac-bites-dust-blade-therapeutics-planned-merger-cancelled

    J. Waldron FIERCEBIOTECH
    14 Jun 2022
    Share Share
    BAC and Blade Therapeutics Postpone Extraordinary Meeting of Shareholders
    BAC and Blade Therapeutics Postpone Extraordinary Meeting of Shareholders

    02 Jun 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/biotech-acquisition-company-and-blade-therapeutics-announce-postponement-of-extraordinary-meeting-of-shareholders-to-approve-proposed-business-combination-301560703.html

    PRNEWSWIRE
    02 Jun 2022
    Share Share
    Blade Tx Presents PC Data on Differentiating Characteristics of Cudetaxestat
    Blade Tx Presents PC Data on Differentiating Characteristics of Cudetaxestat

    18 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220518005033/en

    BUSINESSWIRE
    18 May 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search